Clonal dissemination of


Journal

JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 16 03 2023
accepted: 04 08 2023
medline: 21 8 2023
pubmed: 21 8 2023
entrez: 21 8 2023
Statut: epublish

Résumé

Herein, we describe the epidemiology of carbapenemase-producing Enterobacterales (CPE) before and during the COVID-19 pandemic. Also, we report the emergence of an outbreak of CPE were collected during a period of 3 years from 2019 to 2021. Antimicrobial susceptibility testing for novel βL-βLICs and cefiderocol was performed by MIC test strips and microdilution with iron-depleted broth. WGS was performed on 10 selected isolates using the Illumina platform, and resistome analysis was carried out by a web-based pipeline. Between January 2019 and December 2021, we collected 1430 carbapenemase producers from 957 patients with infections due to CPE. KPC was the most common carbapenemase, followed by VIM, OXA-48 and NDM. During 2021, we identified 78 Our results highlight the need for continuous monitoring of CPE to limit widespread MDR pathogens carrying multiple mechanisms conferring resistance to novel antimicrobial molecules.

Identifiants

pubmed: 37600494
doi: 10.1093/jacamr/dlad099
pii: dlad099
pmc: PMC10433922
doi:

Types de publication

Journal Article

Langues

eng

Pagination

dlad099

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.

Références

Clin Drug Investig. 2020 Oct;40(10):901-913
pubmed: 32700154
J Glob Antimicrob Resist. 2022 Sep;30:262-264
pubmed: 35777673
Int J Mol Sci. 2020 Dec 06;21(23):
pubmed: 33291334
Microbiol Spectr. 2022 Apr 27;10(2):e0008422
pubmed: 35323031
J Glob Antimicrob Resist. 2020 Jun;21:86-90
pubmed: 31639545
Ann Pharmacother. 2020 Dec;54(12):1215-1231
pubmed: 32522005
Antibiotics (Basel). 2022 May 27;11(6):
pubmed: 35740130
Eur J Clin Microbiol Infect Dis. 2022 Apr;41(4):677-680
pubmed: 35088164
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0217120
pubmed: 34031052
Clin Microbiol Infect. 2022 Nov;28(11):1503.e1-1503.e3
pubmed: 35777602
J Clin Med. 2020 Aug 25;9(9):
pubmed: 32854334
Microb Drug Resist. 2022 Sep;28(9):916-920
pubmed: 36112395
Clin Microbiol Infect. 2021 Aug;27(8):1172.e7-1172.e10
pubmed: 33915286
Int J Antimicrob Agents. 2021 Apr;57(4):106324
pubmed: 33746045
J Antimicrob Chemother. 2018 Jun 1;73(6):1525-1529
pubmed: 29566151
Clin Lab Med. 2017 Jun;37(2):303-315
pubmed: 28457352
JAC Antimicrob Resist. 2021 Nov 17;3(4):dlab174
pubmed: 34806011
Antibiotics (Basel). 2022 May 06;11(5):
pubmed: 35625273
Infect Dis Clin North Am. 2020 Dec;34(4):773-819
pubmed: 33011051

Auteurs

Federica Bovo (F)

Division of Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola-Malpighi University Hospital, via G. Massarenti 9-40138, Bologna, Italy.

Stefano Amadesi (S)

Division of Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola-Malpighi University Hospital, via G. Massarenti 9-40138, Bologna, Italy.

Marta Palombo (M)

Division of Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola-Malpighi University Hospital, via G. Massarenti 9-40138, Bologna, Italy.

Tiziana Lazzarotto (T)

Division of Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola-Malpighi University Hospital, via G. Massarenti 9-40138, Bologna, Italy.
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Simone Ambretti (S)

Division of Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola-Malpighi University Hospital, via G. Massarenti 9-40138, Bologna, Italy.
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Paolo Gaibani (P)

Division of Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola-Malpighi University Hospital, via G. Massarenti 9-40138, Bologna, Italy.

Classifications MeSH